case report Eur Surg (2017) 49:187–191 DOI 10.1007/s10353-017-0484-y Hypercalcemia resistant to cinacalcet caused by a mediastinal hyperplastic parathyroid gland in a renal transplant patient Manabu Okada · Kenta Futamura · Takahisa Hiramitsu · Makoto Tsujita · Norihiko Goto · Shunji Narumi · Yoshihiko Watarai · Toshihiro Ichimori · Yoshihiro Tominaga Received: 20 January 2017 / Accepted: 6 June 2017 / Published online: 19 June 2017 © Springer-Verlag GmbH Austria 2017 Summary caused by persistent hyperparathyroidism after renal Background Renal hyperparathyroidism is a common transplantation. Furthermore, we should be extremely complication in patients with chronic kidney disease. careful about hypercalcinuria and nephrocalcinosis Cinacalcet, a kind of calcimimetic, has been reported when we prescribe cinacalcet for patients under hy- to be an effective and safe treatment option in renal percalcemia. transplant patients with hyperparathyroidism. How- ever, some patients require parathyroidectomy due Keywords Chronic kidney disease-mineral and bone to resistance to cinacalcet treatment. It is uncertain disorder · Hyperparathyroidism · Kidney transplanta- when we should give up treatment with cinacalcet tion · Ectopic parathyroid · Parathyroidectomy and perform parathyroidectomy for persistent hyper- parathyroidism. Introduction Case report We experience the ﬁrst documented case in which cinacalcet-resistant hypercalcemia was Renal hyperparathyroidism is a common
European Surgery – Springer Journals
Published: Jun 19, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera